Exelixis (EXEL) Non Operating Income (2011 - 2020)
Exelixis' (EXEL) quarterly Non Operating Income came in at $7.7 million in Q1 2020, up 61.38% year-on-year from $4.8 million in Q1 2019, and up 9.18% quarter-over-quarter from $7.1 million in Q3 2019.
Exelixis (EXEL) Non Operating Income (2011 - 2020) Analysis & Trends
Exelixis' Non Operating Income history runs 10 years deep, the most recent figure standing at $7.7 million for Q1 2020.
- On a quarterly basis, Non Operating Income rose 61.38% year-over-year to $7.7 million in Q1 2020; TTM through Jan 2020 was $28.6 million, a 116.36% increase from a year earlier, with the FY2020 full-year figure at $28.6 million, up 116.36% from the prior year.
- Non Operating Income climbed to $7.7 million in Q1 2020 per EXEL's latest filing, from $7.1 million in the prior quarter.
- Across five years, Non Operating Income topped out at $7.8 million in Q2 2019 and bottomed at -$18.5 million in Q3 2016.
- The 5-year median for Non Operating Income is $2.3 million (2018), against an average of -$971125.0.
- Across the five-year window, Non Operating Income sank 90.02% in 2016 and soared 220.78% in 2018, its largest moves.
- Year by year, Non Operating Income stood at -$11.7 million in 2016, then soared by 112.66% to $1.5 million in 2017, then surged by 220.78% to $4.8 million in 2018, then jumped by 47.82% to $7.1 million in 2019, then rose by 9.18% to $7.7 million in 2020.
- Per Business Quant, the three latest EXEL Non Operating Income figures stand at $7.7 million (Q1 2020), $7.1 million (Q3 2019), and $7.8 million (Q2 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 3, 2020 | 7.70 Mn |
| Sep 27, 2019 | 7.05 Mn |
| Jun 28, 2019 | 7.78 Mn |
| Mar 29, 2019 | 6.11 Mn |
| Dec 28, 2018 | 4.77 Mn |
| Sep 28, 2018 | 3.78 Mn |
| Jun 29, 2018 | 2.63 Mn |
| Mar 30, 2018 | 2.06 Mn |
| Dec 29, 2017 | 1.49 Mn |
| Sep 29, 2017 | 3.41 Mn |
| Jun 30, 2017 | -8.88 Mn |
| Mar 31, 2017 | -3.35 Mn |
| Dec 30, 2016 | -11.74 Mn |
| Sep 30, 2016 | -18.55 Mn |
| Jun 30, 2016 | -9.70 Mn |
| Mar 31, 2016 | -10.09 Mn |
| Sep 30, 2015 | -9.76 Mn |
| Jun 30, 2015 | -12.08 Mn |
| Mar 31, 2015 | -12.41 Mn |
| Dec 31, 2014 | -4.68 Mn |